Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas (original) (raw)
- Original Paper
- Published: 02 June 1998
- X Zhang2,
- Hua Li2,
- Julian L Ostrowski3,
- Barbara Beatty4,
- Marco Venanzoni5,
- Takis Papas2 &
- …
- Arun Seth6
Oncogene volume 16, pages 2459–2467 (1998)Cite this article
- 342 Accesses
- 121 Citations
- 3 Altmetric
- Metrics details
Abstract
To define genes that are essential to the initiation and progression of breast cancer we utilized subtractive hybridization and differential display cloning techniques and isolated over 950 cDNAs from breast cell-lines derived from matched normal and tumor tissue. Of these, 102 cDNAs were characterized by DNA sequencing and Northern blot analysis. GenBank searches showed that one of these genes, T1A12 is identical to mac25, an insulin-like growth factor-binding protein related gene. Antibodies generated against the C-terminal region of the T1A12/mac25 protein were used to investigate its expression in 60 primary breast tissues. Sections of 12 benign, 16 ductal carcinoma in situ and 32 infiltrating ductal carcinoma specimens were examined. Strong immunoperoxidase staining was observed in luminal epithelial cells of normal lobules and ducts, in apocrine cells of cysts and fibroadenomas. Moderate to weak protein expression was found in hyperplastic and DCIS cells, but no specific staining was detected in invasive carcinoma cells. FISH mapping using a PAC clone localized the T1A12/mac25 gene to 4q12-13. Microsatellite length polymorphism was studied using markers for 4q in paired normal and tumor breast tissues. Thirty-three per cent (10/30) of the samples were found to be polymorphic with D4S189 and D4S231 microsatellite markers and LOH was detected in 50% (5/10) of these informative samples. Our data indicate that T1A12/mac25 expression is abrogated during breast cancer progression concomitant with loss of heterozygosity on chromosome 4q. T1A12/mac25 may therefore have a tumor suppressor-like function and its expression could indicate a disease with a more favorable status, having a better prognosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Tumor Biology Center at the University of Freiburg, Freiburg, 79106, FRG
Angelika M Burger - Center for Molecular and Structural Biology, Medical University of South Carolina, Charleston, 29425-2213, South Carolina, USA
X Zhang, Hua Li & Takis Papas - Department of Pathology, Leeds General Infirmary, Leeds, LS2 9JT, UK
Julian L Ostrowski - Princess Margaret Hospital, Toronto, Canada
Barbara Beatty - Cancer Therapy and Prevention Research Association, Rome, Italy
Marco Venanzoni - Department of Laboratory Medicine and Pathobiology, MRC Group in Periodontal Physiology and Women's College Hospital, University of Toronto, Toronto, M5S 1B2, ON, Canada
Arun Seth
Authors
- Angelika M Burger
You can also search for this author inPubMed Google Scholar - X Zhang
You can also search for this author inPubMed Google Scholar - Hua Li
You can also search for this author inPubMed Google Scholar - Julian L Ostrowski
You can also search for this author inPubMed Google Scholar - Barbara Beatty
You can also search for this author inPubMed Google Scholar - Marco Venanzoni
You can also search for this author inPubMed Google Scholar - Takis Papas
You can also search for this author inPubMed Google Scholar - Arun Seth
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Burger, A., Zhang, X., Li, H. et al. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas.Oncogene 16, 2459–2467 (1998). https://doi.org/10.1038/sj.onc.1201772
- Received: 27 August 1997
- Revised: 28 November 1997
- Accepted: 02 December 1997
- Published: 02 June 1998
- Issue Date: 14 May 1998
- DOI: https://doi.org/10.1038/sj.onc.1201772